Most importantly, for Dewmar and its shareholders, the company has successfully managed through a series of 'toxic' financing facilities with two New York City investment groups that converted over 1.27 billion shares which ultimately placed downward pressure on the company's market price, dropping it from a high of $0.50. Dewmar is proud to announce that there are no additional outstanding toxic financing facilities that would allow debtors to convert any more Company stock as of this writing.